No abstract

ObjectivesNurses are at high risk of dysmenorrhoea while working with patients. The study objectives were to: (1) describe the demographic and menstruation characteristics of dysmenorrhoea, knowledge about dysmenorrhoea and menstrual attitudes towards menstruation among dysmenorrhoeal and non-dysmenorrhoeal hospital nurses; (2) identify significant differences between the groups; and (3) examine factors influencing dysmenorrhoea.MethodsThis cross-sectional survey used a structured questionnaire, administered at two hospitals in southern Taiwan. Participants included hospital nurses at least 18 years of age who agreed to participate. All participants were recruited through random sampling. The questionnaire included demographic data, the Dysmenorrhoea Knowledge Scale and Menstrual Attitude Scale (MAS).ResultsA total of 420 nurses completed the questionnaire. Among them, 297 (70.7%) had experienced dysmenorrhoea in the past 6 months and 123 (29.3%) had not. Significant differences in age (P<0.001), marital status (P<0.001), childbearing status (P<0.001), age at menarche (P<0.05) and rotating three shift ratio (P<0.05) were identified between the dysmenorrhoea and non-dysmenorrhoea groups. Analysis of the MAS results revealed significant differences between the groups regarding consideration of menstruation as a debilitating (P<0.001) or bothersome event (P<0.05), anticipation and prediction of menstruation onset (P<0.01) and denial of any effects from menstruation (P<0.001). Results of the multiple logistic regression showed that predictive factors included age <40 years (4.46 vs 1.00), working three shift rotations (2.07 vs 1.00), marital status (2.59 vs 1.00), acknowledging menstruation as a debilitating event (2.72 vs 1.00) and denial of effects from menstruation (2.59 vs 1.00).ConclusionsThese findings could help nursing managers to create a caring and friendly work environment for hospital nurses at risk of dysmenorrhoea.

The prevalence rate of dysmenorrhoea among hospital nurses is high. Most of them take analgesics to reduce pain to return to work. We recommend hospitals to provide women-friendly workplace and empowerment activities to improve the self-care ability and comfort level of nurses during menstruation.

The purpose of this study was to investigate the factors influencing nurses' intentions toward the use of mobile electronic medical records, based on the Theory of Diffusion of Innovations. The cross-sectional study used a structured questionnaire for data collection, focusing on the nurses of a large hospital in southern Taiwan. A total of 720 valid questionnaires were returned yielding a response rate of 82.0%. Multiple regression analysis of the responses identified three innovative characteristics, compatibility, complexity, and observability, as significantly influencing nurses' intentions toward adopting mobile electronic medical records, whereas relative advantage and trialability did not. In addition, nursing seniority affected nurses' intentions significantly toward adopting mobile electronic medical records. Implications of effects of the factors and future research directions are discussed.

These findings suggest a link between macrolevel factors and patient safety outcomes. This study shows that redesigning continuing education programs encourages nurses to participate in patient safety training and understand the nursing unit characteristics that enhance patient safety outcomes to improve the patient safety of nursing units.

Summary Psoriasis is a chronic condition that causes red, scaly patches on the surface of the skin. Treatments may include topical (applied to the skin) creams and oral and injectable medications. Psoriasis can be caused by an autoimmune reaction in which the body's own immune system attacks healthy cells and tissues. To treat moderate‐to‐severe psoriasis, doctors sometimes use specialized medicines called antibodies, which block different parts of the autoimmune reaction that can lead to psoriasis. Although these antibody treatments can be very effective, they do not work in every patient. This study looked at data from two clinical studies of patients with moderate‐to‐severe psoriasis. In each study, patients were initially given one of two antibody treatments: ustekinumab or brodalumab. Some patients initially given ustekinumab or brodalumab did not have adequate skin clearance at week 16; these patients either started taking brodalumab (if they were initially given ustekinumab) or continued taking brodalumab (if they were initially given brodalumab) through to week 52. Patients who experienced inadequate response to their initial treatment after week 16 continued to receive their initial treatment until week 52. At week 52, patients who switched to brodalumab after an inadequate response to ustekinumab showed improvement in skin clearance. Skin clearance in patients who continued taking ustekinumab following inadequate response after week 16 was not as complete as skin clearance in those who switched to brodalumab after an inadequate response at week 16. Additionally, side effects were similar between patients who switched to brodalumab and those who remained on ustekinumab. The results of this study suggest brodalumab may be a successful treatment in patients with moderate‐to‐severe psoriasis who do not experience adequate skin clearance with other psoriasis treatments.

No abstract

No abstract